Is the type of test used for mass colorectal cancer screening a determinant of compliance?. A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy

Cancer Detection and Prevention

Volumn 30, Issue 4, 2006, Pages 347-353

  Federici, Antonio ^a   Marinacci, Chiara ^b   Mangia, Marialuisa ^c   Borgia, Piero ^a   Giorgi Rossi, Paolo ^a   Guasticchi, Gabriella ^a  

^a Agency for Public Health   (Italy)

^b Epidemiology unit Piedmont Region   (Italy)

^c ASL Roma B   (Italy)

Author keywords

Cluster randomized trial; Colonoscopy; Colorectal cancer screening; Compliance; Detection rate; Faecal occult blood test; Flexible sigmoidoscopy; Guaiac test; Provider related factors; Referral rate; Relative risks; Socio economic level

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT REFERRAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOIDOSCOPY; SOCIAL STATUS; SOCIOECONOMICS;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; SIGMOIDOSCOPY; SOCIOECONOMIC FACTORS;

EID: 33748923945     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.03.009     Document Type: Article

References (51)

1. Associazione Italiana Gastroenterologi Ospedalieri. Screening del cancro del colonretto: raccomandazioni. AIGO [last accessed March 13, 2006, http://www.aigo.org/newportal/modules.php?name=Content&pa =showpage&pid=104&i=1].
2. Winawer S.J., Fletcher R.H., Miller L., Godlee F., Stolar M.H., Mulrow C.D., et al. American Gastroenterological Association Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112 (1997) 594-642
3. Smith R.A., Mettlin C.J., Davis K.J., and Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 50 (2000) 34-49
4. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for rectal occult blood. N Engl J Med 328 (1993) 1365-1371
5. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss S.M., Amar S.S., Balfour T.W., et al. Randomized controlled trial of faecal occult blood screen for colorectal cancer. Lancet 348 (1996) 1472-1477
6. Kronborg O., Fenger C., Olsen J., Jergensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with FOBT. Lancet 348 (1996) 1467-1471
7. Greenberg P., Bertario L., Gnauck R., Kronborg O., Hardcastle J., Epstein M., et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonscopy. Am J Gastroent 95 5 (2000) 1331-1338
8. Towler B.P., Irwig L., Glasziou P., Weller D., and Kewenter J. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Syst Rev 2 (2000) CD001216
9. Winawer S.J., St John D.J., Bond J.H., Rozen P., Burt R.W., Waye J.D., et al. Prevention of colorectal cancer: guidelines based on new data WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 73 1 (1995) 7-10
10. United States Preventive Service Task Force. Guide to clinical preventive services. 2nd ed. (1996), Williams & Wilkins, Baltimore
11. Repubblica Italiana. Conferenza permanente Stato Regioni e Province autonome di Trento e Bolzano. Linee Guida per la prevenzione oncologica. May 2, 2001 [S.0. GU n. 100].
12. Agence Nationale d'Accréditation et d'Evaluation en Santé. Prevention, screening, and management of cancer of the colon. Bull Cancer 85 4 (1998) 307-312
13. Commonwealth Minister for Health and Aged Care, National Health and Medical Research Council. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Australia, 2005 [available from URL: http://www.nhmrc.gov.au/publications/synopses/cp106syn.htm].
14. The European Group for Colorectal Cancer Screening Recommendation to include colorectal cancer screening in public health policy. J Med Screen 6 (1999) 80-81
15. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer. Recommendations on population screening for colorectal cancer in New Zealand. N Z Med J 112 1080 (1999) 4-6
16. German Society of Digestive and Metabolic Diseases/Study Group for Gastrointestinal Oncology. Colorectal carcinoma: prevention and early detection in an asymptomatic population - prevention in patients at risk - endoscopic diagnosis, therapy and after-care of polyps and carcinomas. Z Gastroenterol 38 1 (2000) 49-75
17. ®): Screening [last accessed May 11, 2006 http://www.cancer.gov/cancertopics/pdq/screening/colorectal/healthprofes sional].
18. Coombs A., Jones-McLean E., Le-Petit C., Flanagan W., White K., Berthelot J.-M., et al. Technical report for the National Committee on Colorectal Cancer Screening (2002), Health Canada, Ottawa
19. Vernon S.W. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89 (1997) 1406-1422
20. Olynyk J.K., Aquilia S., Fletcher D.R., and Dickinson J.A. Flexible sigmoidoscopy screening for colorectal cancer in average risk subjects: a community based pilot project. Med J Aust 165 (1996) 74-76
21. Senore C., Segnan N., Rossini F.P., Ferraris R., Cavallero M., Coppola F., et al. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 3 (1996) 72-78
22. Thompson R.S., Michnich M.E., Gray J., Frielander L., and Gilson B. Maximizing compliance with haemoccult screening for colon cancer in clinical practice. Med Care 24 (1986) 904-914
23. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359 9314 (2002) 1291-1300
24. Ferrands P.A., and Hardcastle J.D. Factors affecting compliance with screening for colorectal cancer. Commun Med 6 (1984) 12-19
25. Lieberman D.A. Cost effectiveness model for colon cancer screening. Gastroenterology 109 (1995) 1781-1790
26. Box V., Nichols S., Lallemand R.C., Perason P., and Vakil P.A. Haemoccult compliance rates and reasons for non-compliance. Publ Health 98 (1984) 16-25
27. Olschwang S., and Laurent-Puig P. Strategy of screening for patients at high risk of colorectal neoplasm. Gastroenterol Clin Biol 22 Suppl. 3 (1998) S40-S43
28. Richardson J.L., Danley K., Mondrus G.T., Deapen D., and Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Prev Med 24 2 (1995) 166-170
29. Bretagne J.F., and Faivre J. La SNFGE recommande la mise en place d'un dépistage généralisé et organisé di cancer colorectal en France. Gastroenterol Cli Biol 24 (2000) 492-493
30. Robinson M.H.E., Hardcastle J.D., Moss S.M., Amar S.S., Chamberlain J.O., Armitage N.C.M., et al. The risks of screening: data from the Nottingham randomised controlled trial of colorectal cancer. Gut 45 4 (1999) 588-592
31. Federici A., and Chierchini P. Lo screening del cancro colorettale in una Azienda USL del Lazio: risultati preliminari. Proc 11th Natl Congr Associazione Italiana di Epidemiologia; April 9-11. Trieste, Italy. Udine, Agenzia Regionale della Sanità Friuli-Venezia Giulia (1997) 72
32. Michelozzi P., Perucci C.A., Forastiere F., Fusco D., Ancona C., and Dell'orco V. Differenze socioeconomiche nella mortalità a Roma negli anni. Epidemiol Prev 23 (1999) 230-238
33. Zhang J., and Yu K.F. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280 19 (1998) 1690-1691
34. Brevinge H., Lindholm E., Buntzen S., and Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorect Dis 12 (1997) 291-295
35. Verne J.E., Aubrey R., Love S.B., Talbot I.C., and Northover J.M. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ 317 (1998) 182-185
36. Frew E., Wolstenholme J., and Whynes D. Mass population screening for colorectal cancer: factors influencing subjects' choice of screening test. J Health Serv Res Policy 6 2 (2001) 85-91 Apr
37. Saito H., Soma Y., Koeda J., Wada T., Kawaguchi H., Sobue T., et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 61 (1995) 465-469
38. Castiglione G., Zappa M., and Grazzini G. Immunochemical vs. Guaiac faecal occult blood test in a population-based screening programme for colorectal cancer. Br J Cancer 74 (1996) 141-144
39. Castiglione G., Zappa M., Grazzini G., Rubeca T., Turco P., Sani C., et al. Screening for colorectal cancer by faecal occult blood test comparison of immunochemical tests. J Med Screen 7 (2000) 35-37
40. Wong B.C., Wong W.M., Cheung K.L., Tong T.S., Rozen P., Young G.P., et al. A sensitive Guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 18 9 (2003) 941-946
41. Federici A., Giorgi Rossi P., Borgia P., Bartolozzi F., Farchi S., and Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the Guaiac for colorectal cancer screening programs: a cluster randomised controlled trial. J Med Screen 12 (2005) 83-88
42. McCaffery K., Wardle J., Nadel M., and Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen 9 3 (2002) 104-108
43. Tropman Hawley S., Levin B., and Vernon S.W. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev 25 3 (2001) 309-318
44. Giorgi Rossi P., Federici A., Bartolozzi F., Farchi S., Borgia P., and Guasticchi G. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]. BMC Public Health 5 (2005) 139 [e-pub: 22 December, 2005]
45. Segnan N., Senore C., Andreoni B., Aste H., Bonelli L., Crosta C., et al. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"-SCORE. J Natl Cancer Inst 94 December (23) (2002) 1763-1772
46. Atkin W.S., Hart A., Edwards R., McIntyre P., Aubrey R., Wardle J., et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 42 (1998) 560-565
47. Society of Gastroenterology Nurses Associates. Performance of flexible sigmoidoscopy by registered nurses for the purpose of colorectal cancer screening, SGNA guideline. Gastroenterol Nurs 23 2 (2000) 83-85
48. Atkin W.S. Implementing screening for colorectal cancer. BMJ 319 (1999) 1212-1213
49. Froehlich F., Gonvers J.J., Vader J.P., Dubois R.W., Burnand B., and for The European Panel on Appropiateness of Gastrointestinal Endoscopy. Appropriateness of gastrointestinal endoscopy: risk of complications. Endoscopy 31 8 (1999) 684-686
50. Dussault F.-P. Le dépistage du cancer colorectal (1999), CETS, Montréal. http://www.aetmis.gouv.qc.ca/ [available from URL: http://www.aetmis.gouv.qc.ca/]
51. Sorrentino D., Paudano R., Bernardis V., Piccolo A., and Batoli E. Colorectal cancer screening in Italy: feasibility and cost-effectiveness in a model area. Eur J Gastroenterol Hepatol 11 (1999) 655-660